Levetiracetam BEKER® is an antiepileptic drug. It is indicated as monotherapy for the treatment of partial seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy; or dual therapy as indicated on the package leaflet.
| DCI | LEVETIRACETAM |
|---|---|
| Dosage | 250 mg |
| Trade name | LÉVÉTIRACETAM BEKER ® |
| Name of the originator | KEPPRA |
| Presentation | 60 tablets |
| Specialty | Psychiatrie – Antiépileptique |
